Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study

Fig. 1

Percentages of pCR in patients stratified by NLR. In the chi-square test, the patients were divided into two groups based on the NLR cutoff (NLR < 2.06 group and NLR ≥ 2.06 group). Patients in the NLR < 2.06 group showed significantly higher pCR rate than did patients in the NLR ≥ 2.06 group (p < 0.05)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us